{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:38:08Z","timestamp":1720694288425},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.18632\/oncotarget.11620","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T03:51:36Z","timestamp":1472183496000},"page":"64543-64559","source":"Crossref","is-referenced-by-count":6,"title":["T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1\/PD-L1 immune checkpoint blockade therapy"],"prefix":"10.18632","volume":"7","author":[{"given":"Michael","family":"Bruns","sequence":"first","affiliation":[{"name":"Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jara","family":"Wanger","sequence":"additional","affiliation":[{"name":"Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, Hamburg, Germany"},{"name":"Woldsenweg, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Institute for Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf (UKE), University of Hamburg, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Deppert","sequence":"additional","affiliation":[{"name":"Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, Hamburg, Germany"},{"name":"Institute for Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), University of Hamburg, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Sotomayor","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Old","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1053\/j.seminoncol.2015.05.003","article-title":"Cancer and the Immune System: Basic Concepts and Targets for Intervention","volume":"42","author":"Pardoll","year":"2015","journal-title":"Semin Oncol"},{"key":"5","first-page":"357","article-title":"Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway","volume":"7","author":"Postow","year":"2014","journal-title":"Pharmgenomics Pers Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/cas.12695","article-title":"Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy","volume":"106","author":"Tamada","year":"2015","journal-title":"Cancer Sci"},{"key":"7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000445335","article-title":"Checkpoint Inhibitors and Their Application in Breast Cancer","volume":"11","author":"Seliger","year":"2016","journal-title":"Breast Care (Basel)"},{"key":"8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.onc.1203281","article-title":"A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland","volume":"19","author":"Deppert","year":"2000","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"publisher","first-page":"38487","DOI":"10.18632\/oncotarget.5750","article-title":"An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses","volume":"6","author":"Deppert","year":"2015","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ijc.23317","article-title":"Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis","volume":"122","author":"Tolstonog","year":"2008","journal-title":"Int J Cancer"},{"key":"11","first-page":"168","article-title":"Aberrant Proliferation of Differentiating Alveolar Cells Induces Hyperplasia in Resting Mammary Glands of SV40-TAg Transgenic Mice","volume":"4","author":"Bohn","year":"2014","journal-title":"Front Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/ijc.27880","article-title":"CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis","volume":"132","author":"Gunes","year":"2013","journal-title":"Int J Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ijc.27783","article-title":"Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression","volume":"132","author":"Gunes","year":"2013","journal-title":"Int J Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ijc.27941","article-title":"Transcription factors link mouse WAP-T mammary tumors with human breast cancer","volume":"132","author":"Tolstonog","year":"2013","journal-title":"Int J Cancer"},{"key":"15","article-title":"PD-1 and Its Ligands in Tolerance and Immunity","author":"Sharpe","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Kivork","year":"2014","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4049\/jimmunol.1502291","article-title":"NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1\/PD-L1 Interactions with Dendritic Cells","volume":"197","author":"Fuertes","year":"2016","journal-title":"J Immunol"},{"key":"19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ijc.29369","article-title":"Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination","volume":"137","author":"Alves","year":"2015","journal-title":"Int J Cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/eji.1830230720","article-title":"Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes","volume":"23","author":"Reimann","year":"1993","journal-title":"Eur J Immunol"},{"key":"21","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.156.10.3919","article-title":"Protective immunity in BALB\/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes","volume":"156","author":"Lehmann-Grube","year":"1996","journal-title":"J Immunol"},{"key":"22","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1128\/JVI.75.22.10593-10602.2001","article-title":"Simian virus 40 large- T-antigen-specific rejection of mKSA tumor cells in BALB\/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells","volume":"75","author":"Deppert","year":"2001","journal-title":"J Virol"},{"key":"23","doi-asserted-by":"crossref","first-page":"e12103","DOI":"10.1371\/journal.pone.0012103","article-title":"Tumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system","volume":"5","author":"Tolstonog","year":"2010","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1002\/ijc.29186","article-title":"Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice","volume":"136","author":"Wegwitz","year":"2015","journal-title":"Int J Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12885-015-1165-5","article-title":"Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells","volume":"15","author":"Wegwitz","year":"2015","journal-title":"BMC Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0042-6822(90)90527-X","article-title":"Mode of replication of lymphocytic choriomeningitis virus in persistently infected cultivated mouse L cells","volume":"177","author":"Lehmann-Grube","year":"1990","journal-title":"Virology"},{"key":"27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000150518","article-title":"Protection of mice by an attenuated variant against the wild-type lymphocytic choriomeningitis virus","volume":"40","author":"Gegin","year":"1997","journal-title":"Intervirology"},{"issue":"Pt 12","key":"28","first-page":"3431","article-title":"Characterization of a virus variant produced by L cells persistently infected with lymphocytic choriomeningitis virus","volume":"75","author":"Bruns","year":"1994","journal-title":"J Gen Virol"},{"key":"29","first-page":"238","article-title":"Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice","volume":"532","author":"Lohler","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"30","first-page":"132","article-title":"Management of Regional Metastases of Malignant Salivary Gland Neoplasms","volume":"78","author":"Bradley","year":"2016","journal-title":"Adv Otorhinolaryngol"},{"key":"31","doi-asserted-by":"publisher","first-page":"41274","DOI":"10.18632\/oncotarget.8978","article-title":"Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint","volume":"7","author":"Cang","year":"2016","journal-title":"Oncotarget"},{"key":"32","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Zaheer","year":"2015","journal-title":"N Engl J Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2015.04.007","article-title":"Distinct mechanisms of tumor resistance to NK killing: of mice and men","volume":"42","author":"Pardoll","year":"2015","journal-title":"Immunity"},{"key":"34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/phar.1714","article-title":"PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses","volume":"36","author":"Adams","year":"2016","journal-title":"Pharmacotherapy"},{"key":"35","doi-asserted-by":"publisher","first-page":"33498","DOI":"10.18632\/oncotarget.9256","article-title":"Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab","volume":"7","author":"Hodge","year":"2016","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.4049\/jimmunol.1401936","article-title":"PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells","volume":"194","author":"Ha","year":"2015","journal-title":"J Immunol"},{"key":"37","doi-asserted-by":"crossref","first-page":"e0140483","DOI":"10.1371\/journal.pone.0140483","article-title":"Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis","volume":"10","author":"van Tendeloo","year":"2015","journal-title":"PLoS One"},{"key":"38","first-page":"4","article-title":"An open-source computational and data resource to analyze digital maps of immunopeptidomes","author":"Navarro","year":"2015","journal-title":"Elife"},{"key":"39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Patsch","year":"2015","journal-title":"Nature"},{"key":"40","doi-asserted-by":"crossref","first-page":"e1086862","DOI":"10.1080\/2162402X.2015.1086862","article-title":"Tumor-intrinsic oncogene pathways mediating immune avoidance","volume":"5","author":"Gajewski","year":"2016","journal-title":"Oncoimmunology"},{"key":"41","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1038\/sj.onc.1208557","article-title":"Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice","volume":"24","author":"Deppert","year":"2005","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/312548a0","article-title":"Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo","volume":"312","author":"Waldmann","year":"1984","journal-title":"Nature"},{"key":"43","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.4049\/jimmunol.144.5.1926","article-title":"Virus-specific delayed-type hypersensitivity (DTH). Cells mediating lymphocytic choriomeningitis virus-specific DTH reaction in mice","volume":"144","author":"Lehmann-Grube","year":"1990","journal-title":"J Immunol"},{"key":"44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/277322a0","article-title":"Simian virus 40 specific proteins on surface of HeLa cells infected with adenovirus 2--SV40 hybrid virus Ad2+ND2","volume":"277","author":"Pates","year":"1979","journal-title":"Nature"},{"key":"45","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1099\/vir.0.2008\/003541-0","article-title":"Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates","volume":"89","author":"Bruns","year":"2008","journal-title":"J Gen Virol"},{"key":"46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:17:13Z","timestamp":1718763433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":46,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016,10,4]]}},"alternative-id":["11620","27579535"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11620","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]}}}